New treatment options for tuberculosis (TB) strains that are resistant to antibiotics have been found by University of Otago researchers, paving the way for fresh strategies to combat the illness that claims the lives of approximately 4,000 people daily.
Hyderabad (Telangana) [India], March 22 (ANI/BusinessWire India): GV Research Platform (GVRP), a renowned provider of preclinical research services, has announced a partnership with Nexel, a leading specialist in induced pluripotent stem cell (iPSC) technology. Through this partnership, GVRP
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden discovered that the hunger hormone ghrelin can boost the heart's pump capacity in patients with heart failure in a clinical investigation. The findings were published in the European Heart Journal.
Sometimes the finest things in life happen by coincidence, when we happen to be in the right location at the right moment. Now, Japanese researchers have discovered a method to ensure that new treatments are delivered to the proper area in the body and at the right moment in illness progress
Researchers have uncovered a previously unknown contributor to damaging blood vessel formation in the eye, which may lead to new treatments for blinding macular degeneration and other frequent causes of vision loss.
Researching the wall separating the circulatory system from the neurological system has been highly difficult or limited in its use of models. In order to properly investigate potential new treatments for brain tumours, researchers have created a more realistic model.
Despite the fact that migraines are painful both physically and financially, recently found genetic reasons by QUT researchers may pave the path for brand-new treatments and preventative medications.
The findings of a recent study suggest that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) -- the most common form of the chronic autoimmune disease lupus.
Researchers have discovered an unknown biological process that controls the production of vital cells that carry oxygen throughout the body. The discovery could help doctors develop new treatments for anaemias that affect millions of people.
According to a study, patients with thyroid eye disease treated with the minimally invasive insulin-like growth factor I blocking antibody teprotumumab saw improvements in their symptoms, appearance, and quality of life.
Researchers describe the impact of epigenetics on cancer treatment and how it has become a crucial tool to improve early detection, predict disease progression and become a target for new treatments.
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.